A Study to Evaluate the Efficacy and Safety of AK102 in Patients With Hyperlipidemia
Clinical trial NCT05255094 · COMPLETED
Trial details
- NCT number
- NCT05255094
- Sponsor
- Akeso
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-03
- Primary completion
- 2022-06-22
- Enrollment
- 464
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.